562 related articles for article (PubMed ID: 23454684)
1. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
2. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease.
Ji P; Chen C; Hu Y; Zhan Z; Pan W; Li R; Li E; Ge HM; Yang G
Biol Pharm Bull; 2015; 38(1):1-6. PubMed ID: 25744451
[TBL] [Abstract][Full Text] [Related]
4. Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line.
Kuo KK; Chang JS; Wang KC; Chiang LC
Am J Chin Med; 2009; 37(2):383-94. PubMed ID: 19507280
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
[TBL] [Abstract][Full Text] [Related]
6. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
Feng Yeh C; Wang KC; Chiang LC; Shieh DE; Yen MH; San Chang J
J Ethnopharmacol; 2013 Jul; 148(2):466-73. PubMed ID: 23643542
[TBL] [Abstract][Full Text] [Related]
7. Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization.
Yen MH; Huang CI; Lee MS; Cheng YP; Hsieh CJ; Chiang LC; Chang JS
Kaohsiung J Med Sci; 2018 Mar; 34(3):150-159. PubMed ID: 29475462
[TBL] [Abstract][Full Text] [Related]
8.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
9. Virucidal activity and the antiviral mechanism of acidic polysaccharides against Enterovirus 71 infection in vitro.
Li Z; Cui B; Liu X; Wang L; Xian Q; Lu Z; Liu S; Cao Y; Zhao Y
Microbiol Immunol; 2020 Mar; 64(3):189-201. PubMed ID: 31785100
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway.
Kim SH; Lee J; Jung YL; Hong A; Nam SJ; Lim BK
J Microbiol Biotechnol; 2020 Jan; 30(1):38-43. PubMed ID: 31752055
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro.
Yeo SG; Song JH; Hong EH; Lee BR; Kwon YS; Chang SY; Kim SH; Lee SW; Park JH; Ko HJ
Arch Pharm Res; 2015 Feb; 38(2):193-202. PubMed ID: 24752860
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
15. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
Wu KX; Chu JJ
Antiviral Res; 2017 Jul; 143():122-133. PubMed ID: 28427827
[TBL] [Abstract][Full Text] [Related]
16. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
17. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
18. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
[TBL] [Abstract][Full Text] [Related]
19. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro.
Pu X; Wang H; Li Y; Fan W; Yu S
Virol Sin; 2013 Dec; 28(6):352-9. PubMed ID: 24254889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]